CB
Canal Biosciences, Inc.
SEC filingBiotechnology · Lowell, MA
Amount raised$2.3Msold at filing
Total offering$3.2M$915K still open
Investors in the raise18count reported to the SEC
FiledApr 13, 2026first sale Mar 18, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Christopher BenoitExecutive Officer, Director
Jack PercoskieExecutive Officer
Yu ZhengExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.